CNTX

Context Therapeutics Inc. SEC filings

Every EDGAR filing for Context Therapeutics Inc. (CNTX), newest first, with AI summaries and stories.

Ticker
CNTX
CIK
1842952
Latest filing
Aug 14

Next: 10-Q expected ~Nov 6 (deadline Nov 16)

Watch in the app Get the app

Get an email when Context Therapeutics Inc. files

One email per filing with the plain-English summary. Confirm once; unsubscribe in one click.

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

  8. ROUTINE4Context Therapeutics Inc.CNTX

    6 insider filings

    Jennifer Evans Stacey, insider filing for CNTX

    Show all 6
    • 4Insider filing for CNTX
    • 4Insider filing for CNTX
    • 4Insider filing for CNTX
    • 4Insider filing for CNTX
    • 4Insider filing for CNTX
    • 4Insider filing for CNTX

    Jennifer Evans Stacey, reporting

  13. ROUTINESCHEDULE 13G/AContext Therapeutics Inc.CNTX

    2 13G filings

    Ownership stake disclosure by Blue Owl Capital Holdings LP (amended)

    Show all 2
    • SCHEDULE 13G/AOwnership stake disclosure (amended)
    • SCHEDULE 13GOwnership stake disclosure

    Blue Owl Capital Holdings LP, filed by

  28. ROUTINE4Context Therapeutics Inc.CNTX

    4 insider filings

    Alex C. Levit, insider filing for CNTX

    Show all 4
    • 4Insider filing for CNTX
    • 4Insider filing for CNTX
    • 4Insider filing for CNTX
    • 4Insider filing for CNTX

    Alex C. Levit, reporting

  29. ROUTINESCHEDULE 13G/AContext Therapeutics Inc.CNTX

    2 13G filings

    Ownership stake disclosure by GREAT POINT PARTNERS LLC (amended)

    Show all 2
    • SCHEDULE 13G/AOwnership stake disclosure (amended)
    • SCHEDULE 13G/AOwnership stake disclosure (amended)

    GREAT POINT PARTNERS LLC, filed by

Older filings on EDGAR